Please login to the form below

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

During the COVID-19 pandemic, multiple sclerosis (MS) experts were receiving many questions regarding the safety and efficacy of COVID-19 vaccination in patients receiving treatment for MS. The challenge was developing robust guidance in a timely manner with a goal of providing clarity on vaccine timing, efficacy, and safety, to support healthcare professionals and their patients.

An international Steering Committee of 10 MS experts came together to discuss, refine, and finalise 13 clinical recommendations. A further 28 MS experts from 19 countries also voted on the recommendations and helped to reach robust consensus through a virtual voting platform within a 90-day timeframe.

“Merck KGaA and Bedrock identified a beautifully simple solution to a pressing need. The judges recognised that achieving actional consensus on guidelines is always challenging, which is exacerbated by HCPs’ workloads, but the results achieved here are impressive. The approach was bold and imaginative, and the execution very well planned and delivered” PMEA Judging Panel 2022.

Stephen Marchant, MD of Bedrock said “We would like to add congratulations to Hashem Salloukh for partnering and trusting us with this critical project that provided a clear patient benefit. I would also like to thank my Bedrock team. This award is a testament to their freethinking, agility, and our belief that no two business challenges are the same.”

If you are looking for a team of freethinkers with bold and imaginative approaches to medical communications get in touch  freethinking@bedrock-health.com

28th November 2022

Share

Tags

Company Details

Bedrock Healthcare Communications

01252 240200

Contact Website

Address:
One Fleet
Ancells Road
Fleet
Hampshire
GU51 2UN

Latest content on this profile

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence
Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.
Bedrock Healthcare Communications
MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP
Two additional leadership moves also strengthen management team
Bedrock Healthcare Communications
The value medical communications bring to phase 2/3 of drug development
Bedrock’s Head of Strategy, Derek Annan, explains why the development of successful communication requires not only planning, strategy and execution (and measurement), it also needs to be able to respond to the unexpected.
Bedrock Healthcare Communications
Bedrock expands growing strategy and scientific teams
Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.
Bedrock Healthcare Communications
Bedrock Healthcare Communications appoints Louise Adamson as Head of Scientific Services
Louise Adamson joins Bedrock as Head of Scientific Services to drive scientific and strategic excellence and grow and develop the scientific team.
Bedrock Healthcare Communications
Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards
The award recognises outstanding achievement in flexing thinking and processes to ensure success.
Bedrock Healthcare Communications